FI103408B1 - Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi

Info

Publication number: FI103408B1
Authority: FI; Finland
Prior art keywords: hydrogen; preparation; therapeutically useful; halogen; alkyl
Prior art date: 1990-09-24

Application number

FI914275A

Other languages

English (en)

Swedish (sv)

Other versions

FI914275L (fi

FI103408B (fi

FI914275A0 (fi

Inventor

Soeren-Peter Olesen

Frank Waetjen

Original Assignee

Neurosearch As

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-09-24

Filing date

1991-09-11

Publication date

1999-06-30

1991-09-11 Application filed by Neurosearch As filed Critical Neurosearch As

1991-09-11 Publication of FI914275A0 publication Critical patent/FI914275A0/fi

1992-03-25 Publication of FI914275L publication Critical patent/FI914275L/fi

1999-06-30 Application granted granted Critical

1999-06-30 Publication of FI103408B1 publication Critical patent/FI103408B1/fi

1999-06-30 Publication of FI103408B publication Critical patent/FI103408B/fi

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Polyesters Or Polycarbonates (AREA)
Graft Or Block Polymers (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

FI914275A 1990-09-24 1991-09-11 Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaiste n valmistamiseksi FI103408B (fi)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US58690090A	1990-09-24	1990-09-24
US58690090		1990-09-24

Publications (4)

Publication Number	Publication Date
FI914275A0 FI914275A0 (fi)	1991-09-11
FI914275L FI914275L (fi)	1992-03-25
FI103408B1 true FI103408B1 (fi)	1999-06-30
FI103408B FI103408B (fi)	1999-06-30

Family

ID=24347548

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI914275A FI103408B (fi)	1990-09-24	1991-09-11	Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaiste n valmistamiseksi

Country Status (15)

Country	Link
EP (1)	EP0477819B1 (fi)
JP (1)	JP3203017B2 (fi)
KR (1)	KR100195770B1 (fi)
AT (1)	ATE119887T1 (fi)
AU (1)	AU635440B2 (fi)
CA (1)	CA2052041C (fi)
DE (1)	DE69108156T2 (fi)
DK (1)	DK0477819T3 (fi)
ES (1)	ES2072504T3 (fi)
FI (1)	FI103408B (fi)
IE (1)	IE67133B1 (fi)
NO (1)	NO180795C (fi)
NZ (1)	NZ239540A (fi)
PT (1)	PT99032B (fi)
ZA (1)	ZA916805B (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0520200B1 (en) *	1991-06-24	1998-02-18	Neurosearch A/S	Imidazole compounds, their preparation and use
US5158969A (en) *	1991-08-21	1992-10-27	Neurosearch A/S	Indole derivatives as potassium channel blockers
US5232899A (en) *	1992-06-08	1993-08-03	Imperial Chemical Industries Plc	Benzoxazolinones and their use as herbicides
AU5433594A (en) *	1992-11-19	1994-06-08	Dainippon Pharmaceutical Co. Ltd.	3,4-dihydro-1-(2-hydroxyphenyl)-2(1h)-quinoxalinone derivative and related compound
DK154092D0 (da) *	1992-12-23	1992-12-23	Neurosearch As	Imidazolforbindelser, deres fremstilling og anvendelse
DK28893D0 (da) *	1993-03-15	1993-03-15	Neurosearch As	Benzimidazole derivater, deres fremstilling og anvendelse
DK41193D0 (da) *	1993-04-07	1993-04-07	Neurosearch As	Ionkanalaabnere
US5637470A (en) *	1994-05-13	1997-06-10	Merck & Co., Inc.	Screening array using cells expressing recombinant α and β subunits of the mammalian large-conductance (maxi-K) potassium channel
FR2722190B1 (fr) *	1994-07-05	1996-10-04	Sanofi Sa	Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
US5565483A (en) *	1995-06-07	1996-10-15	Bristol-Myers Squibb Company	3-substituted oxindole derivatives as potassium channel modulators
TW504504B (en) *	1996-11-26	2002-10-01	Bristol Myers Squibb Co	4-aryl-3-hydroxyquinolin-2-one derivatives as ion channel modulators
US5893085A (en) *	1997-06-10	1999-04-06	Phillips; Ronald W.	Dynamic fuzzy logic process for identifying objects in three-dimensional data
WO1999009983A1 (en) *	1997-08-28	1999-03-04	Bristol-Myers Squibb Company	4-aryl-3-aminoquinoline-2-one derivatives as potassium channel modulators
EP1144387A1 (en)	1998-12-04	2001-10-17	Neurosearch A/S	New benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
PL196955B1 (pl) *	1998-12-04	2008-02-29	Bristol Myers Squibb Co	Pochodna 3-podstawionego -4-arylochinolin -2-onu jako modulator kanałów potasowych, jej zastosowanie i kompozycja farmaceutyczna
WO2004002962A1 (en) *	2002-06-26	2004-01-08	Poseidon Pharmaceuticals A/S	Novel benzimidazol-2-one derivatives and their use
WO2004064835A1 (en) *	2003-01-17	2004-08-05	Neurosearch A/S	Use of ion channel modulating agents for treating pain
ES2222831B2 (es) *	2003-07-30	2006-02-16	Laboratorios Del Dr. Esteve, S.A.	Combinacion de principio activo que comprende un compuesto 2,5-dihidroxibencenosulfonico y un modulador de los canales de k+.
PE20060572A1 (es) *	2004-07-27	2006-06-27	Novartis Ag	Compuestos de benzoimidazolona como inhibidores de hsp90
EP2143724B1 (en)	2007-04-18	2013-12-11	Kissei Pharmaceutical Co., Ltd.	Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH460028A (de) *	1965-01-22	1968-07-31	Wander Ag Dr A	Verfahren zur Herstellung von Benzimidazolonderivaten
FR1561830A (fi) *	1968-05-08	1969-03-28
GB1408408A (en) *	1971-11-24	1975-10-01	Beecham Group Ltd	Benzimidazole derivatives
GB1476949A (en) *	1974-11-20	1977-06-16	Wyeth John & Brother Ltd	Imidazo-1,2-a-benzimidazole and pyrimido-1,2-a-benzimidazole derivatives their preparation and their pharmaceutical compositions
CH622009A5 (fi) *	1976-06-11	1981-03-13	Ciba Geigy Ag
DE3042481A1 (de) *	1980-11-11	1982-06-16	A. Nattermann & Cie GmbH, 5000 Köln	(omega)-(2-oxo-benzazolinyl)-alkansaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische praeparate
CA1327579C (en) *	1986-02-03	1994-03-08	Frans Eduard Janssens	Anti-histaminic compositions containing n-heterocyclyl-4-piperidinamines

1991
- 1991-08-26 NZ NZ239540A patent/NZ239540A/en not_active IP Right Cessation
- 1991-08-28 AU AU82767/91A patent/AU635440B2/en not_active Ceased
- 1991-08-28 ZA ZA916805A patent/ZA916805B/xx unknown
- 1991-09-11 FI FI914275A patent/FI103408B/fi not_active IP Right Cessation
- 1991-09-11 IE IE319791A patent/IE67133B1/en not_active IP Right Cessation
- 1991-09-20 KR KR1019910016522A patent/KR100195770B1/ko not_active Expired - Fee Related
- 1991-09-20 JP JP24194691A patent/JP3203017B2/ja not_active Expired - Fee Related
- 1991-09-23 AT AT91116148T patent/ATE119887T1/de not_active IP Right Cessation
- 1991-09-23 NO NO913728A patent/NO180795C/no unknown
- 1991-09-23 DK DK91116148.7T patent/DK0477819T3/da active
- 1991-09-23 ES ES91116148T patent/ES2072504T3/es not_active Expired - Lifetime
- 1991-09-23 CA CA002052041A patent/CA2052041C/en not_active Expired - Fee Related
- 1991-09-23 DE DE69108156T patent/DE69108156T2/de not_active Expired - Fee Related
- 1991-09-23 EP EP91116148A patent/EP0477819B1/en not_active Expired - Lifetime
- 1991-09-24 PT PT99032A patent/PT99032B/pt not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0477819A2 (en)	1992-04-01
EP0477819B1 (en)	1995-03-15
NZ239540A (en)	1993-11-25
ATE119887T1 (de)	1995-04-15
CA2052041A1 (en)	1992-03-25
ZA916805B (en)	1992-05-27
NO913728D0 (no)	1991-09-23
KR100195770B1 (ko)	1999-06-15
DE69108156T2 (de)	1995-07-06
IE67133B1 (en)	1996-03-06
CA2052041C (en)	2002-08-20
NO180795B (no)	1997-03-17
NO913728L (no)	1992-03-25
IE913197A1 (en)	1992-02-25
FI914275L (fi)	1992-03-25
NO180795C (no)	1997-06-25
JP3203017B2 (ja)	2001-08-27
ES2072504T3 (es)	1995-07-16
DK0477819T3 (da)	1995-07-17
EP0477819A3 (en)	1992-05-20
JPH04305568A (ja)	1992-10-28
AU635440B2 (en)	1993-03-18
AU8276791A (en)	1992-03-26
PT99032A (pt)	1993-11-30
FI103408B (fi)	1999-06-30
PT99032B (pt)	1999-02-26
DE69108156D1 (de)	1995-04-20
FI914275A0 (fi)	1991-09-11
KR920006327A (ko)	1992-04-27

Publication	Publication Date	Title
FI103408B1 (fi)	1999-06-30	Menetelmä terapeuttisesti käyttökelpoisten bentsimidatsolijohdannaisten valmistamiseksi
ATE117295T1 (de)	1995-02-15	4-oxochinolin-3-carbonsäure-derivate, ihre herstellung und ihre verwendung.
ATE145201T1 (de)	1996-11-15	Dihydro-isoquinolinderivate
CA2089767A1 (en)	1992-02-22	Pyridinyl thiadiazolyl- and oxadiazolyl derivatives
ES484059A1 (es)	1980-04-16	Procedimiento para proteger materiales queratinicos contra el ataque de insectos devoradores de queratina
RU94019425A (ru)	1995-09-27	Производные изатиноксима, способ их получения, фармацевтическая композиция и способ лечения
ATE79257T1 (de)	1992-08-15	Verwendung von tetrahydrobenz(c,d>indol-6carboxamiden zur herstellung von arzneimitteln zur behandlung von angstzustaenden.
DE69021347D1 (de)	1995-09-07	Isatinderivate, ihre Herstellung und Verwendung.
NO173137C (no)	1993-11-03	Analogifremgangsmaate for fremstilling av terapeutisk aktive forbindelser
ATE137759T1 (de)	1996-05-15	S'-adenosyl-methionin-decarboxylase-inhibitoren
DE69414017D1 (de)	1998-11-26	Benzimidazolderivate, ihre Herstellung und Verwendung
ES2069901T3 (es)	1995-05-16	Procedimiento para la obtencion de acido aminometanofosfonico y acidos aminoetil-fosfinicos.
ATE22289T1 (de)	1986-10-15	N-(3-trifluormethylphenyl)-n'-propargylpiperazi , seine herstellung und verwendung.
ATE198750T1 (de)	2001-02-15	Isatinoxim-derivate, ihre herstellung und verwendung
ATE212842T1 (de)	2002-02-15	Quinoxalin-derivate zur behandlung von tinnitus
ES8504712A1 (es)	1985-05-01	Un procedimiento para preparar nuevas dihidropiridinas
DE69116187D1 (de)	1996-02-22	Verwendung eines Dihydropyridins zur Verbesserung der Blutzirkulation des inneren Ohres
ATE114307T1 (de)	1994-12-15	Phenylglycidamide, verwendbar in der herstellung von alpha-hydroxy-beta-sulfido-arylpropionsäure- derivaten.
JPS53119825A (en)	1978-10-19	1,3-dithioallophanate derivatives, their preparation, insecticides, acaricides, and bactericides for agricultural and horticultural uses

Legal Events

Date	Code	Title	Description
2009-03-31	MA	Patent expired